ConductScience.org, home

Trial · NCT00232141

Outcomes33

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline for Numerical Rating Scale (NRS) Pain Scores at Endpoint-LOCF (Last Observation Carried Forward) Relative to BaselineBaseline, Week 14
ITT population (ie, full analysis set)=all randomized participants who took at least 1 dose \& had at least 1 post-randomization efficacy assessment. The endpoint-LOCF mean value was computed from last 7 diary entries (Day 2 up to and including the day after the last dose w/n Dose-Adjustment or Maintenance phase (up to Day 99).
score on scaleLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDChange in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward)Baseline, Weeks 1 - 14 and Endpoint-BOCFITT population; n = number of participants with data for analysis reported per week per treatment group (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDResponders- Decreases of at Least 50% in Mean Weekly Pain ScoreWeeks 1-14 Endpoint BOCF (modified baseline observation carried forward)ITT population; n = number of participants with data for analysis reported per week per treatment group (n=pregabalin, placebo), BOCF = modified baseline observation carried forwardparticipantsNUMBER
OTHER_PRE_SPECIFIEDResponders - Decreases of at Least 30% in Mean Weekly Pain ScoreWeeks 1-14 endpoint BOCFITT population; n = number of participants with data for analysis reported per week per treatment group (n=pregabalin, placebo); BOCF = modified baseline observation carried forwardparticipantsNUMBER
SECONDARYChange From Baseline for MOS (Medical Outcomes Study)-Sleep Subscales and Sleep Problem IndicesBaseline, Week 14ITT Population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline for Hospital Anxiety and Depression Scale (HADS) SubscalesBaseline, Week 14ITT populationscore on scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline for Modified Brief Pain Inventory-Short Form (mBPI-sf) ScoresBaseline, Week 14ITT Population; n = number of participants with data for analysis reported (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline for NRS-Sleep Interference ScoresBaseline, Week 14ITT Populationscore on scaleLEAST_SQUARES_MEAN
SECONDARYCategorized Patient Global Impression of Change (PGIC)Baseline, Week 14ITT PopulationparticipantsNUMBER
SECONDARYPatient Global Impression of Change (PGIC) RatingBaseline, Week 14, Endpoint-LOCFITT PopulationparticipantsNUMBER
SECONDARYChange in Neuropathic Pain Symptom Inventory (NPSI) Subscores and Total Intensity ScoresBaseline, Week 14ITT Population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYChange in Quantitative Assessment of Neuropathic Pain (QANeP)Baseline, Week 14ITT Population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDDuration Adjusted Average Change From Baseline in NRS Pain ScoresWeekly: Week 1 - Week 14ITT Populationscore on scaleLEAST_SQUARES_MEAN
SECONDARYChange in NRS-Sleep Interference ScoresBaseline, Weeks 1-14ITT Population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYShift in Hospital Anxiety and Depression (HADS) SubscalesBaseline, Week 14ITT PopulationparticipantsNUMBER
SECONDARYChange in Brief Pain Inventory-short Form (BPI-sf) Scores (The Worst Pain in the Past 24 Hours)Baseline, Weeks 1,2,6,10,14, Endpoint - LOCFITT population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYChange in Brief Pain Inventory-sf Scores (The Least Pain in the Past 24 Hours)Baseline, Weeks 1,2,6,10,14, Endpoint-LOCFITT population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYChange in Brief Pain Inventory-sf Scores (Average Level of Pain in the Past 24 Hours)Baseline, Weeks 1,2,6,10,14 and EndpointITT population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYChange in Brief Pain Inventory-sf Scores (How Much Pain Are You Having Right Now)Baseline, Weeks 1,2,6,10,14 and EndpointITT population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN
SECONDARYChange in Brief Pain Inventory-sf Scores (During the Past 24 Hours, How Pain Has Interfered With Your General Activity)Baseline, Weeks 1,2,6,10,14 and EndpointITT population; n = number of participants with data for analysis (n=pregabalin, placebo).score on scaleLEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00232141/outcomes